Medical Care in China

herpes simplex
Treatment in China

Provide a clear and complete coordinated pathway from expert assessment to treatment and rehabilitation.

Get a Care Plan and Cost Estimate
Comprehensive coverage of skin diseasesincluding inflammation, infection, immune disorders, and tumors.
Accurate differential diagnosiscombines dermoscopy, pathology, and laboratory tests.
Chronic disease managementinvolves long-term management of diseases such as psoriasis and eczema.
Skin repair treatmentfocuses on improving pigmentation, scars, and skin function.

Condition Guide

About herpes simplex

Understand the condition, common triggers and treatment options that may require specialist assessment.

Disease Introduction

Herpes simplex is a viral skin disease caused by the herpes simplex virus (HSV-1/HSV-2). It often appears as clusters of small blisters on the corners of the mouth, lips, or genitals. It tends to recur when fatigued, when cold, or when the immune system is weakened. There is currently no cure, but proper antiviral treatment can significantly reduce the frequency of flare-ups.


Cutting-edge high-precision diagnostic and treatment technologies

  1. New drug for drug-resistant HSV : Prilivir (AIC316) is a novel oral helicase-primase inhibitor that remains effective against HSV-1/HSV-2 resistant to nucleoside analogs and phosphonoformate sodium. Its pivotal Phase III PRIOH-1 trial will yield positive results in February 2026, with a better skin lesion healing rate than the control, providing a new option for refractory/drug-resistant patients.
  2. Long-term suppression therapy : For patients with frequent relapses (≥6 times per year), oral valacyclovir or acyclovir can be administered daily for 6-12 months to reduce the relapse frequency by 70%-80%, reduce the risk of asymptomatic viral shedding and sexual transmission, and lower the risk of transmission.
  3. mRNA vaccines under development : There are no genital herpes vaccines approved globally; a Chinese HSV-2 mRNA vaccine has been approved for clinical trials (registration number CTR20252798), and BaiKe Bio will start Phase I trials in September 2025; Moderna's therapeutic vaccine mRNA-1608 was terminated in November 2025.

Care Overview

herpes simplex Treatment in China

The medical team will develop a personalized protocol based on the pathology type, stage, genetic test, previous treatment history, and the patient's physical condition.

Leading Specialists

Trusted Expertise Across Leading Specialties

Zhu Zhonggang

First department head, tenured professor

Dermatology

Research area : Prevention and research of occupational skin diseases. Cutting-edge technologies: research on asphalt toxicity, prevention and treatment of rice paddy dermatitis, prevention and treatment of oil paint dermatitis; research and development of industrial protective creams. Academic Highlights: One of the founders of modern dermatology in China; received the first national-level scientific research achievement award from Ruijin Hospital after the founding of New China in 1954; formulated the n

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Sun Qiuning

Professor , specializing in cosmetic dermatology and immune skin diseases

Dermatology

Research areas: Facial cosmetic-related dermatology, minimally invasive facial rejuvenation treatments, and autoimmune and infectious skin diseases. Cutting-edge technology: Proficient in minimally invasive cosmetic treatments such as Botox injections, hyaluronic acid fillers, and laser therapy; specializing in the diagnosis and treatment of autoimmune skin diseases such as scleroderma and psoriasis. Completed two years of postdoctoral research at the University of Texas. Specializes in: facial cosmetic d

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Zuo Yagang

Professor , specializing in bullous skin diseases and laser cosmetic procedures

Dermatology

Research areas: Diagnosis and treatment of bullous skin diseases, psoriasis, vitiligo, and cosmetic laser therapy. Cutting-edge technology: Focusing on the clinical characteristics of bullous pemphigoid induced by immune checkpoint inhibitors, and leading the development of the "Expert Consensus on the Diagnosis and Treatment of Bullous Pemphigoid (2025 Edition)". Extensive clinical experience has been accumulated in the fields of autoimmune bullous diseases and laser cosmetic procedures. Specializes in t

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Liu Jie

Professor , specializing in dermatological imaging and skin tumors

Dermatology

Research areas: Diagnosis and treatment of skin tumors, lymphomas, acne, and other diseases; dermoscopy and skin imaging diagnosis. Cutting-edge technology: Chief editor of "Peking Union Medical College Hospital Dermatoscopy Atlas" and "Immersive Dermatoscopy: Peking Union Medical College Hospital Dermatoscopy Learning Notes," and author of 4 consensus statements on skin imaging. Promoting the standardized application and widespread use of dermatoscopy techniques in clinical practice. Specializes in: skin

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences logo Affiliated Hospital Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Pan Meng

Chief Physician, Professor, Doctoral Supervisor, Director of Dermatology

Dermatology

- Research areas : Pathogenesis of bullous skin diseases (pemphigoid, bullous pemphigoid) and autoimmune skin diseases. - Cutting-edge technologies: dynamic monitoring of pemphigus autoantibodies; rituximab and novel biological agents for the treatment of refractory pemphigus. - Diseases specializing in: pemphigus vulgaris, bullous pemphigoid, IgA bullous disease, and other autoimmune herpes diseases. - Academic Highlights: Deputy Head of the Experimental Group of the Dermatology and Venereology Branch of

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Cao Hua

Associate Chief Physician, Doctoral Supervisor

Dermatology

-Research areas : Dermatomyositis, connective tissue disease-related skin diseases, severe inflammatory skin diseases. - Cutting-edge technologies: Detection of autoantibody profiles for dermatomyositis; MDT combined intervention for dermatomyositis and interstitial lung disease. - Areas of expertise: Dermatomyositis, skin lesions of systemic lupus erythematosus, scleroderma, severe drug eruption. - Academic Highlights: Key member of the department's critical connective tissue disease subspecialty, partic

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine logo Affiliated Hospital Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

Next Step

Get a Care Plan
and Cost Estimate.

Tell us about your diagnosis and needs, and our team will help screen the right hospital and explain the next steps.

Email:goldentcm@163.com

Get a Care Plan and Estimate

Once you submit your information, a member of our support team will reach out to you within one business day.